Cite
MLA Citation
W Sandborn et al.. “DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S060–S061. http://access.bl.uk/ark:/81055/vdc_100092359492.0x00000a